BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright ©The Author(s) 2025.
World J Virol. Dec 25, 2025; 14(4): 111810
Published online Dec 25, 2025. doi: 10.5501/wjv.v14.i4.111810
Table 1 Summary of characteristics of the included studies
Ref.
Country
Data source
Number of newly diagnosed
Number of people received RTRI test
RTRI coverage
Prevalence of RTRI recent infection
Prevalence of RITA recent infection
Prevalence of
Reclassification
from recent to long-term infection
Quality scores
Truong et al[14], 2022Eswatini, Nigeria, Rwanda, Thailand, Uganda, Vietnam, ZambiaHIV program2314104168818.08
Aungkulanon et al[22], 2022BangkokHIV
program
129169453.88.57.88.58
Simanovong et al[23], 2022ThailandHIV program19615378.14.63.914.37
Okiror et al[37], 20241UgandaHIV program------7
Herce et al[28], 2024ZambiaHIV program34432293.6-3.2-9
Mochama et al[17], 20241KenyaHIV program------8
Ouk et al[18], 20221CambodiaHIV program------7
Lerdtriphop et al[19], 20221ThailandHIV program------8
Rice et al[12], 2020Kenya and
Zimbabwe
HIV program1582126980.216.97.25.99
Negedu-Momoh et al[29], 2021NigeriaSurvey---5.13.04.29
Welty et al[16], 2020KenyaHIV program62853284.711.79.419.49
Voetsch et al[5], 2021≥ 10 countries2Survey---10.31.5-9
Rwibasira et al[24], 2021RwandaHIV program10701791974.09.56.036.48
Mohloanyane et al[35], 2023LesothoSurvey---9.97.425.09
Alemu et al[25], 2022EthiopiaHIV program5689312955.0-14.2-8
Parmley et al[30], 2022ZimbabweSurvey---8.61.187.57
Young et al[31], 2023KenyaSurvey---11.85.686.68
Telford et al[8], 2022MalawiHIV program9295916898.66.13.345.39
Ang et al[32], 2021SingaporeSurvey---25.719.026.18
Msukwa et al[26], 2020MalawiHIV program140221383898.76.33.243.19
Agyeman et al[33], 2022MalawiHIV program---19.713.929.38
Singh et al[34], 2023South AfricaLaboratory---43.038.610.38
Zhou et al[36], 2023ChinaHIV program----19.5-7
Saito et al[11], 20231RwandaHIV program------7
Zhu et al[27], 2020ChinaHIV program1157115299.617.915.115.19
Table 2 Subgroup analysis on the prevalence of recency coverage, rapid testing for recent infection, recent infection testing algorithm and reclassification among newly diagnosed people living with human immunodeficiency virus in low- and mid-income countries
Sources of data
P value
HIV program, % (95%CI)
Laboratory/surveys, % (95%CI)
RTRI-recent HIV infection11 (8-10)14 (8-23)0.510
RITA-recent HIV infection6 (5-6)5 (2-13)0.440